
About this episode
Last May, a 12-year-old with sickle cell anemia was the first person to receive a new gene therapy to treat the disease. The process is painful, expensive, and still frightening and uncertain, but biomedical researchers are cautiously calling it a “cure.”
Guests:
Gina Kolata, medical reporter for the New York Times
Deb and Keith Cromer, parents to Kendric Cromer, the first person in the world to go through a commercially approved gene therapy for sickle cell anemia.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Podcast production by Evan Campbell, Patrick Fort, and Cheyna Roth.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time What Next | Daily News and Analysis publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from What Next | Daily News and Analysis

The 9/11 Panopticon
What Next | Daily News and Analysis

Did ICE Drive Him to His Death?
What Next | Daily News and Analysis

Dems Can Beat MAGA. Here’s How.
What Next | Daily News and Analysis

Question Everything: The Sunscreen Paradox
What Next | Daily News and Analysis